Gene Query: CERS4

Dataset Description Geneva Score
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 66.98
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 56.17
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 34.55
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 33.3
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 29.64
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 29.55
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 25.12
RNA expression following TMPRSS11B overexpression or depletion 20.08
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 18.3
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 17.51
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 17.51
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 17.31
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 17.25
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 16.3
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 16.17
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 15.98
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 15.75
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 15.0
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 14.77
NR2F2 study 14.32
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 14.32
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 14.29
RNA-sequencing of human liver tissue 13.81
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 13.6
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 13.6
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 12.79
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 12.37
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 12.19
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 11.83
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 11.56
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 11.22
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 11.17
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 11.06
Genome-wide functional assessment of enhancer activities in the human genome 11.03
Ro60-knockout cells 10.98
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 10.98
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 10.72
Ectoderm specification of H1 human embryonic stem cells 10.42
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 10.23
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 9.92
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 9.92
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 9.84
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 9.84
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.83
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.83
RNA-Sequencing of HepG2 cells treated with TGFBeta 9.81
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.65
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 9.47
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 9.47
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 9.44
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 9.41
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 9.38
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 9.12
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 9.12
iPSC-Derived Cholangiocytes 9.05
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 8.96
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 8.61
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 8.53
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 8.53
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 8.45
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 8.3
Gene expression in GBM with Cav3.2 inhibition 8.29
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 8.1
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 8.1
Lipid degradation promotes prostate cancer cell survival 8.02
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.01
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 8.0
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 7.99
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 7.99
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 7.85
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 7.7
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 7.65
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 7.65
Transcriptome analysis of human lung epithelial cells 7.64
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 7.41
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 7.41
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 7.41
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 7.4
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 7.39
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 7.34
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.05
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 6.97
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 6.95
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.94
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 6.83
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 6.81
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 6.73
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 6.7
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 6.64
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 6.64
Identification of HOXB13 target genes responsive to BET inhibitors 6.58
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 6.54
RNA-seq analyses of human prostate cancer cells 6.44
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.41
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 6.39
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 6.35
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 6.27
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 6.21
High-efficiency RNA-based reprogramming of human primary fibroblasts 6.2
RNAseq analysis of ESRP regulated splicing events in prostate cancer 6.18
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 6.14
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 6.08
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 6.03
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.97
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 5.96
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 5.95
Role for citron kinase in prostate cancer growth 5.83
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 5.71
Overexpression and knockdown experiment for circCSNK1G3 5.68
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 5.62
Seletive inhibition of CDK9 in DLBCL cell lines 5.59
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 5.57
Gene expressions of H9s in different culture systems 5.49
Mechanistic Model-Guided Study of Embryonic Morphogenesis 5.45
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 5.43
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.29
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 5.27
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 5.23
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 5.23
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 5.22
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 5.22
RNA-seq data from human lymphoma cell lines 5.18
ChIP-seq and RNA-seq from human lymphoma cell lines 5.18
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 5.1
Evolution of a transcriptional regulator from a transmembrane nucleoporin 5.1
RNA-seq in HepG2 and IMR90 cells 5.1
The Human Testis Cell Atlas via Single-cell RNA-seq 5.09
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 5.04
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 5.04
Primary Human B-cell Temporal Response to CD40L Stimulation 4.99
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 4.96
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.94
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 4.88
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 4.88
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 4.88
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.85
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 4.83
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 4.76
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.75
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.73
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 4.7
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.7
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 4.66
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 4.64
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 4.62
Androgen Receptor-regulated genes in prostate cancer cells 4.62
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.61
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.61
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 4.61
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 4.61
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 4.59
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 4.57
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 4.55
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.51
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 4.46
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 4.46
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.46
High-throughput sequencing of pluripotent cells 4.42
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 4.42
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 4.37
CDK4/6 inhibitor resistance in prostate cancer 4.31
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.27
Differentially expressed vascular development genes for iPSC-ECs from CDI 4.26
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 4.24
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 4.19
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 4.19
Neonatal and adult human testis defined at the single-cell level 4.18
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.18
Evaluating pre-clinical models for studying NASH driven HCC. 4.18
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 4.17
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.13
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.13
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 4.09
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.06
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 4.05
Non-coding regions are the main source of tumor-specific antigens [human] 4.05
Non-coding regions are the main source of tumor-specific antigens 4.05
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 4.04
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 4.04
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 4.03
FGF2 regulation of gene expression in stable inducible Neurons 4.02
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 4.02
Be1 and Be2 B cells are transcriptionally distinct 3.99
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 3.98
Silencing p300 in MCF7 cells to study expression and alternative splicing 3.96
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.96
Bone marrow derived human B cells [normal proB] 3.93
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 3.91
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 3.91
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 3.89
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 3.89
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 3.85
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 3.82
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 3.82
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.79
Paxillin regulates genomic networks in prostate cancer [LNCaP] 3.78
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 3.74
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 3.74
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 3.73
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 3.73
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 3.71
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 3.64
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 3.63
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.62
RNA-seq of naive and primed ES cells (NHSM) 3.6
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 3.59
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 3.59
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.58
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 3.57
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.56
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 3.54
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 3.51
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 3.51
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.44
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.44
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.41
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 3.4
LncRNA-GAS5 negative regulation of YAP-target genes expression 3.4
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 3.4
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.38
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.36
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 3.36
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.35
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.32
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.32
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 3.3
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.3
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.3
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 3.29
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 3.27
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 3.27
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 3.25
RNA-Seq from early time points in the kidney differentiation protocol 3.25
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 3.25
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 3.2
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.17
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.17
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.17
The pause-initiation limit restricts transcription activation in human cells 3.16
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 3.12
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 3.11
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 3.1
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.06
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 3.0
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 3.0
RNA-seq analysis and shRNA screen of breast cancer 2.99
RNA-seq analysis of breast cancer 2.99
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.99
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 2.98
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.96
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.96
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.96
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 2.95
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.94
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.92
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.85
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 2.84
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 2.82
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.81
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 2.79
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 2.76
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 2.71
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 2.7
Genome-wide Analysis of Chromatin Interactions in Human Cells 2.7
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.69
IRF2 is a master regulator of human keratinocyte stem cell fate 2.68
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 2.68
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.68
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 2.68
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.65
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 2.63
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 2.61
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 2.61
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 2.61
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 2.58
Tpl-2 and MEK small molecule inhibitors 2.56
Tpl-2 small molecule project 2.56
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.56
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.56
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.54
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.54
circNFIB suppresses lymphatic metastasis of pancreatic cancer 2.53
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 2.5
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.46
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.45
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.44
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.41
Characterization of parental and rociletinib-resistant derived H1975 cell lines 2.37
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.36
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 2.35
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.35
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 2.32
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.3
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.3
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 2.28
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 2.27
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 2.27
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 2.25
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 2.25
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 2.25
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 2.25
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 2.24
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.23
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 2.23
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 2.22
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.19
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.17
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.17
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.16
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.16
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 2.15
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 2.14
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 2.12
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 2.11
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 2.1
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 2.1
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.08
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 2.07
Functional Haploid Human Oocytes Generated from Polar Body Genomes 2.07
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.07
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 2.06
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 2.04
Reprogrammed myeloid cell transcriptomes in NSCLC 2.04
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 1.99
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 1.99
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.97
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.95
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.92
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.92
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.9
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.9
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 1.9
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 1.9
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 1.88
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 1.88
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.88
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.88
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.87
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.87
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.87
DIGIT regulates endoderm differentiation of human embryonic stem cells 1.86
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 1.84
RNA-seq of SCLC PDX models treated with EP 1.8
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 1.78
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.74
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.71
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 1.71
mRNA sequencing of oropharyngeal cancer cell lines 1.7
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 1.68
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 1.66
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.66
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.66
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 1.64
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.61
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.6
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.56
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.56
Human islets of varying quality: the good, the (not so) bad and the ugly 1.54
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 1.47
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.44
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 1.43
Transciptomic profiling of human fetal lung samples 1.43
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 1.42
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 1.42
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.42
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.41
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.41
BACH2 in human plasma cell fate decision 1.4
MCF-7 as a model for functional analysis of breast cancer risk variants 1.39
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.39
Induced DNA demethylation, genome instability and transcription 1.38
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.38
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 1.37
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.37
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.36
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 1.35
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 1.35
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.35
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.32
Effect of PBK knockdown on C4-2 cell transcriptome 1.3
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 1.27
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.27
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.27
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 1.25
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 1.25
BASP1 modifies the Tamoxifen response 1.2
A single cell reference map for human blood and tissue T cell activation 1.2
H1609088 Human RNA-Sequencing 1.2
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.18
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.18
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.18
Proliferation-correlated expression 1.18
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.15
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.06
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.06
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.06
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.05
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.05
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.04
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.03
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.95
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.94
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.94
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.94
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.93
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.92
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.92
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.92
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.92
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.91
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 0.91
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.9
Expression analysis of the TAF1 syndrome 0.9
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.88
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.88
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.85
Next Generation Sequencing of human SMA and healthy control Motor Neurons 0.83
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.83
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.83
Hepatic transcriptome of pediatric hepatoblastoma. 0.81
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.8
Epigenomic conservation of transposable element silencing 0.77
Epigenomic conservation of transposable element silencing [RNA-seq] 0.77
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.75
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.75
Energy Metabolism during Anchorage-Independence 0.75
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.74
Leucegene: ALL sequencing 0.71
Effect of PRDM11 depletion in U2932 cells 0.7
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.69
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.68
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.67
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.67
Gene expression analysis of breast cancer cell-lines 0.65
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.65
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.63
Leucegene: AML sequencing (part 6) 0.63
Iron response of HepG2 cells 0.61
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.61
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.6
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.59
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 0.57
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.57
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 0.5
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.49
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.49
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.49
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.49
Deep RNA sequencing of the human placental transcriptome 0.48
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.46
Preclinical model of obesity and ER-positive breast cancer 0.41
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 0.4
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.4
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.39
ML29755 RNA-seq data 0.39
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.37
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.35
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.35
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.35
Expression profiles of the four human major ectodermal lineages 0.33
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 0.32
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 0.32
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.31
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.31
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.31
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.28
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.27
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.27
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.27
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.26
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.26
Transcriptomic analysis of frontal fibrosing alopecia 0.26
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.24
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.24
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.24
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.23
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.22
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.2
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.2
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.2
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.2
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.18
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 0.16
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.16
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.15
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.15
Clinker: visualizing fusion genes detected in RNA-seq data 0.14
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.1
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.09
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.09
iPSC derived motor neuron cultures from C9ORF72 carriers 0.08
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.06
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.06
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.06
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 0.06
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.05
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.04
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.02
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.01
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation